DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)

China flag China · Delayed Price · Currency is CNY
17.18
-0.22 (-1.26%)
Jul 25, 2025, 2:45 PM CST
-1.26%
Market Cap19.82B
Revenue (ttm)26.70B
Net Income (ttm)976.30M
Shares Out1.14B
EPS (ttm)0.86
PE Ratio20.18
Forward PE17.63
Dividend0.62 (3.63%)
Ex-Dividend DateJun 19, 2025
Volume4,828,509
Average Volume5,984,949
Open17.40
Previous Close17.40
Day's Range17.16 - 17.49
52-Week Range11.92 - 19.00
Beta0.46
RSI58.77
Earnings DateAug 29, 2025

About SHA:603233

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. It provides Chinese and western patent medicines, ginseng tonic medicinal materials and Chinese herbal pieces, health care products, medical equipment, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 43,532
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603233
Full Company Profile

Financial Performance

In 2024, SHA:603233's revenue was 26.50 billion, an increase of 8.01% compared to the previous year's 24.53 billion. Earnings were 914.75 million, a decrease of -21.58%.

Financial Statements

News

There is no news available yet.